Clostridium perfringens endophthalmitis following cataract surgery.
Romsaitong
D P
DP
Department of Ophthalmology, Catholic Medical Centers of Brooklyn and Queens, Flushing, NY 11366, USA. romsaitong@aol.com
Grasso
C M
CM
D000368:Aged; D000900:Anti-Bacterial Agents; D001201:Ascites / Q000473:pathology; D002387:Cataract Extraction / Q000009:adverse effects*; D003015:Clostridium Infections / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D003016:Clostridium perfringens / Q000302:isolation & purification*; D003110:Colonic Neoplasms / Q000473:pathology / Q000556:secondary; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015353:Eye Enucleation; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents